India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Bhavin Mukund
Read More
May 25, 2026
- CCI Closes Decade-Old Case Against 12 Delhi Hospitals Over Alleged Overpricing
- Max Healthcare Approves ₹1,400 Crore Investment for 712-bed Lucknow Hospital
- Delhi’s RML Hospital Admits Season’s First Heat Stroke Patient, 24-Year-Old Youth Critical
- AI Must Be Guided by Ethics and Equity in Healthcare: Nadda